1802 related articles for article (PubMed ID: 29954454)
21. Assessment of the synbiotic properites of human milk oligosaccharides and Bifidobacterium longum subsp. infantis in vitro and in humanised mice.
Musilova S; Modrackova N; Hermanova P; Hudcovic T; Svejstil R; Rada V; Tejnecky V; Bunesova V
Benef Microbes; 2017 Apr; 8(2):281-289. PubMed ID: 28116928
[TBL] [Abstract][Full Text] [Related]
22. Lactobacillus paracasei HII01, xylooligosaccharides, and synbiotics reduce gut disturbance in obese rats.
Thiennimitr P; Yasom S; Tunapong W; Chunchai T; Wanchai K; Pongchaidecha A; Lungkaphin A; Sirilun S; Chaiyasut C; Chattipakorn N; Chattipakorn SC
Nutrition; 2018 Oct; 54():40-47. PubMed ID: 29705500
[TBL] [Abstract][Full Text] [Related]
23. Prebiotic, Probiotic, and Synbiotic Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
McFarlane C; Ramos CI; Johnson DW; Campbell KL
J Ren Nutr; 2019 May; 29(3):209-220. PubMed ID: 30366767
[TBL] [Abstract][Full Text] [Related]
24. Prebiotic Galactooligosaccharide Metabolism by Probiotic Lactobacilli and Bifidobacteria.
Thongaram T; Hoeflinger JL; Chow J; Miller MJ
J Agric Food Chem; 2017 May; 65(20):4184-4192. PubMed ID: 28466641
[TBL] [Abstract][Full Text] [Related]
25. The Impact of Probiotics, Prebiotics, and Synbiotics during Pregnancy or Lactation on the Intestinal Microbiota of Children Born by Cesarean Section: A Systematic Review.
Martín-Peláez S; Cano-Ibáñez N; Pinto-Gallardo M; Amezcua-Prieto C
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057522
[TBL] [Abstract][Full Text] [Related]
26. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans.
Davis LM; Martínez I; Walter J; Goin C; Hutkins RW
PLoS One; 2011; 6(9):e25200. PubMed ID: 21966454
[TBL] [Abstract][Full Text] [Related]
27. Effect of probiotic, prebiotic, and synbiotic on the gut microbiota of autistic children using an in vitro gut microbiome model.
Duque ALRF; Demarqui FM; Santoni MM; Zanelli CF; Adorno MAT; Milenkovic D; Mesa V; Sivieri K
Food Res Int; 2021 Nov; 149():110657. PubMed ID: 34600659
[TBL] [Abstract][Full Text] [Related]
28. β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria.
Wilson B; Rossi M; Kanno T; Parkes GC; Anderson S; Mason AJ; Irving PM; Lomer MC; Whelan K
Am J Gastroenterol; 2020 Jun; 115(6):906-915. PubMed ID: 32433273
[TBL] [Abstract][Full Text] [Related]
29. Fructooligosaccharide (FOS) and Galactooligosaccharide (GOS) Increase Bifidobacterium but Reduce Butyrate Producing Bacteria with Adverse Glycemic Metabolism in healthy young population.
Liu F; Li P; Chen M; Luo Y; Prabhakar M; Zheng H; He Y; Qi Q; Long H; Zhang Y; Sheng H; Zhou H
Sci Rep; 2017 Sep; 7(1):11789. PubMed ID: 28924143
[TBL] [Abstract][Full Text] [Related]
30. Probiotic or synbiotic alters the gut microbiota and metabolism in a randomised controlled trial of weight management in overweight adults.
Hibberd AA; Yde CC; Ziegler ML; Honoré AH; Saarinen MT; Lahtinen S; Stahl B; Jensen HM; Stenman LK
Benef Microbes; 2019 Mar; 10(2):121-135. PubMed ID: 30525950
[TBL] [Abstract][Full Text] [Related]
31. Effect of galactooligosaccharides and Bifidobacterium animalis Bb-12 on growth of Lactobacillus amylovorus DSM 16698, microbial community structure, and metabolite production in an in vitro colonic model set up with human or pig microbiota.
Martinez RC; Cardarelli HR; Borst W; Albrecht S; Schols H; Gutiérrez OP; Maathuis AJ; de Melo Franco BD; De Martinis EC; Zoetendal EG; Venema K; Saad SM; Smidt H
FEMS Microbiol Ecol; 2013 Apr; 84(1):110-23. PubMed ID: 23167835
[TBL] [Abstract][Full Text] [Related]
32. Effect of Probiotic Lactobacillus salivarius UBL S22 and Prebiotic Fructo-oligosaccharide on Serum Lipids, Inflammatory Markers, Insulin Sensitivity, and Gut Bacteria in Healthy Young Volunteers: A Randomized Controlled Single-Blind Pilot Study.
Rajkumar H; Kumar M; Das N; Kumar SN; Challa HR; Nagpal R
J Cardiovasc Pharmacol Ther; 2015 May; 20(3):289-98. PubMed ID: 25331262
[TBL] [Abstract][Full Text] [Related]
33. Effects of Supplementation of the Synbiotic Ecologic® 825/FOS P6 on Intestinal Barrier Function in Healthy Humans: A Randomized Controlled Trial.
Wilms E; Gerritsen J; Smidt H; Besseling-van der Vaart I; Rijkers GT; Garcia Fuentes AR; Masclee AA; Troost FJ
PLoS One; 2016; 11(12):e0167775. PubMed ID: 27936169
[TBL] [Abstract][Full Text] [Related]
34. [A machine learning model based on initial gut microbiome data for predicting changes of Bifidobacterium after prebiotics consumption].
Luo YM; Liu FT; Chen MX; Tang WL; Yang YL; Tan XL; Zhou HW
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Mar; 38(3):251-260. PubMed ID: 29643029
[TBL] [Abstract][Full Text] [Related]
35. The gut microbiome stability is altered by probiotic ingestion and improved by the continuous supplementation of galactooligosaccharide.
Ma C; Wasti S; Huang S; Zhang Z; Mishra R; Jiang S; You Z; Wu Y; Chang H; Wang Y; Huo D; Li C; Sun Z; Sun Z; Zhang J
Gut Microbes; 2020 Nov; 12(1):1785252. PubMed ID: 32663059
[TBL] [Abstract][Full Text] [Related]
36. In vitro fermentation of different fructo-oligosaccharides by Bifidobacterium strains for the selection of synbiotic combinations.
Valdés-Varela L; Ruas-Madiedo P; Gueimonde M
Int J Food Microbiol; 2017 Feb; 242():19-23. PubMed ID: 27866040
[TBL] [Abstract][Full Text] [Related]
37. Consumption of a Bifidobacterium bifidum Strain for 4 Weeks Modulates Dominant Intestinal Bacterial Taxa and Fecal Butyrate in Healthy Adults.
Gargari G; Taverniti V; Balzaretti S; Ferrario C; Gardana C; Simonetti P; Guglielmetti S
Appl Environ Microbiol; 2016 Oct; 82(19):5850-9. PubMed ID: 27451450
[TBL] [Abstract][Full Text] [Related]
38. In vitro screening of probiotic lactic acid bacteria and prebiotic glucooligosaccharides to select effective synbiotics.
Grimoud J; Durand H; Courtin C; Monsan P; Ouarné F; Theodorou V; Roques C
Anaerobe; 2010 Oct; 16(5):493-500. PubMed ID: 20670686
[TBL] [Abstract][Full Text] [Related]
39. Genetic mechanisms of prebiotic oligosaccharide metabolism in probiotic microbes.
Goh YJ; Klaenhammer TR
Annu Rev Food Sci Technol; 2015; 6():137-56. PubMed ID: 25532597
[TBL] [Abstract][Full Text] [Related]
40. Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease.
Scorletti E; Afolabi PR; Miles EA; Smith DE; Almehmadi A; Alshathry A; Childs CE; Del Fabbro S; Bilson J; Moyses HE; Clough GF; Sethi JK; Patel J; Wright M; Breen DJ; Peebles C; Darekar A; Aspinall R; Fowell AJ; Dowman JK; Nobili V; Targher G; Delzenne NM; Bindels LB; Calder PC; Byrne CD
Gastroenterology; 2020 May; 158(6):1597-1610.e7. PubMed ID: 31987796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
